Genetic polymorphisms of human UDP-glucuronosyltransferases (UGT) genes and cancer risk

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    Identification of genetic polymorphisms that contribute to the risk of developing cancers is important for cancer prevention. The most recent human genome GRCh38/hg38 assembly (2013) reveals thousands of genetic polymorphisms in human uridine diphosphoglucuronosyltransferase (UGT) genes. Among these, a large number of polymorphisms at the UGT1A and UGT2B genes have been shown to modulate UGT gene promoter activity or enzymatic activity. Glucuronidation plays an important role in the metabolism and clearance of endogenous and exogenous carcinogenic compounds, and this reaction is primarily catalyzed by the UGT1A and UGT2B enzymes. Therefore, it has long been hypothesized that UGT polymorphisms that reduce the capacity to glucuronidate carcinogens and other types of cancer-promoting molecules (e.g. sex hormones) are associated with an increased risk of developing cancers. A large number of case-control studies have investigated this hypothesis and these studies identified numerous UGT polymorphisms in UGT1A and UGT2B genes as genetic risk factors for a wide variety of cancers, including bladder, breast, colorectal, endometrial, esophageal, head and neck, liver, lung, prostate, and thyroid. These UGT polymorphisms may be cancer causative polymorphisms, or be linked to as yet undefined causative polymorphisms, either in UGT genes or neighboring genes. This article presents a comprehensive review of these case-control studies, discusses current areas of uncertainty, and highlights future research directions in this field.

    Original languageEnglish
    Pages (from-to)47-69
    Number of pages24
    JournalDrug Metabolism Reviews
    Volume48
    Issue number1
    DOIs
    Publication statusE-pub ahead of print - 2016

    Fingerprint Dive into the research topics of 'Genetic polymorphisms of human UDP-glucuronosyltransferases (UGT) genes and cancer risk'. Together they form a unique fingerprint.

  • Cite this